Combined use of a fibrate and orlistat for the treatment of obesity

Details for Australian Patent Application No. 2004218938 (hide)

Owner Fournier Laboratories Ireland Limited

Inventors Edgar, Alan

Agent Spruson & Ferguson

Pub. Number AU-B-2004218938

PCT Pub. Number WO2004/080450

Priority 03290625.7 13.03.03 EP

Filing date 12 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 9 April 2009

International Classifications

A61K 31/192 (2006.01)

A61K 31/216 (2006.01)

A61K 31/223 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/080450 Priority application(s): WO2004/080450

9 April 2009 Application Accepted

  Published as AU-B-2004218938

6 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218941-Method and device for nebulisation

2004218935-Heat-generating mixture and device and method for heat generation